Benefits
UTI Prevention (Multiple RCTs)
Multiple Pacran RCTs demonstrate reduced UTI incidence in women with recurrent UTIs. 500 mg/day Pacran has clinical evidence for urinary tract health support.
A-Type Proanthocyanidins (PACs)
Cranberry's unique A-type PACs prevent E. coli adhesion to bladder wall — primary UTI prevention mechanism. Whole cranberry provides PAC plus additional cranberry compounds.
Frequent Urination Support in Women
Recent Pacran research established benefits for alleviating frequent urination in women.
Whole Cranberry Distinction
Pacran uses whole cranberry providing comprehensive phytochemistry — A-type PACs PLUS organic acids, flavonoids, anthocyanins.
Convenient Daily Dosing
500 mg single-capsule daily dose convenient for consistent urinary health support.
Mechanism of action
A-Type PAC Anti-Adhesion
Cranberry's unique A-TYPE PACs (most berries have B-type) prevent type-1 fimbriated E. coli adhesion to bladder uroepithelium. Without adhesion, bacteria cannot establish infection.
Bacterial Adhesion vs Antimicrobial
Cranberry doesn't kill bacteria — prevents adhesion. Mechanism distinct from antibiotics. Supports bacteria flushing via urination.
Whole Cranberry Phytochemistry
Beyond PACs: organic acids may modify urine pH; flavonoids provide antioxidant; comprehensive cranberry profile.
Clinical trials
Multiple Pacran 500 mg/day RCTs in women with recurrent UTIs.
Women with recurrent UTIs.
Reduced UTI incidence vs placebo across studies.
Recent clinical study of Pacran for alleviating frequent urination in women.
Women with frequent urination.
Improvements in frequency markers; established additional women's urological applications.